Skip to Content
Merck
CN

G9664

Sigma-Aldrich

FreAlagin™ R gelatin

lyophilized powder

Synonym(s):

Gelatin from porcine skin

Sign Into View Organizational & Contract Pricing

Select a Size

About This Item

CAS Number:
9000-70-8
EC Number:
232-554-6
UNSPSC Code:
12352202

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

Porcine skin

sterility

aseptically processed

form

lyophilized powder

mol wt

200-10,000

technique(s)

ELISA: suitable
cell culture | mammalian: suitable
immunocytochemistry: suitable
western blot: suitable

impurities

endotoxin, tested

storage temp.

2-8°C

Looking for similar products? Visit Product Comparison Guide

General description

FreAlagin gelatins are non-antigenic and low allergenic. They are recommended for use as stabilizers or blocking reagents.

Other Notes

Gelatin is a heterogeneous mixture of water-soluble proteins of high average molecular masses, present in collagen. Proteins are extracted by boiling the relevant skin, tendons, ligaments, bones, etc. in water. Type A gelatin is derived from acid-cured tissue. Type B is derived from lime-cured tissue.

Legal Information

FreAlagin is a trademark of Miyagi Chemical Industries Co., Ltd.

Storage Class Code

13 - Non Combustible Solids

WGK

nwg

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
090K1480

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Melika Sarem et al.
Carbohydrate polymers, 93(2), 635-643 (2013-03-19)
In the engineering of soft tissues, designing the scaffolds with adequate strength and controllable biodegradation properties are essential. To fulfill such design criteria gelatin/carbohydrate chitosan (G/CC) scaffolds have gained much attention in engineering replacement of soft tissues. In this research
L Du et al.
Poultry science, 92(9), 2463-2474 (2013-08-21)
Gelatins were prepared from chicken and turkey heads in a series of batch extractions at 2 different temperatures (50 and 60°C), and their composition and functional properties were evaluated. Gelatin yield from chicken and turkey heads was 52.29 and 62.76%
Shutaro Gunji et al.
Surgery, 154(5), 991-999 (2013-09-07)
Peritoneal carcinomatosis is a poor prognostic factor for patients with gastrointestinal, gynecologic, and pancreatic cancer. Cisplatin (CDDP) is among the most effective anti-cancer agents, although its adverse effects remain unresolved. For the treatment of peritoneal carcinomatosis with high-dose CDDP, it
Dai-Hung Ngo et al.
Food chemistry, 143, 246-255 (2013-09-24)
Skin gelatin of skate (Okamejei kenojei) was hydrolyzed using Alcalase, flavourzyme, Neutrase and protamex. It was found that the Alcalase hydrolysate exhibited the highest angiotensin-I converting enzyme (ACE) inhibitory activity. Then, Alcalase hydrolysate was further hydrolyzed with protease and separated
Ole Bayer et al.
Critical care medicine, 41(11), 2532-2542 (2013-08-28)
To determine clinical outcomes of synthetic colloids, tetrastarch, and gelatin, used before and after cardiac surgery. Prospective observational cohort study. Fifty-bed cardiac ICU. Six thousand four hundred seventy-eight consecutive patients with cardiopulmonary bypass surgery. Fluid therapy in the operating room
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service